Dusting PowderMRP Under Process
Official PMBI MRP is being updated for catalog code 2556.
Locate Jan Aushadhi KendraClinical Overview
Fluconazole is a synthetic bistriazole antifungal agent on the WHO Model List of Essential Medicines. It selectively inhibits fungal lanosterol 14-alpha-demethylase, disrupting ergosterol synthesis with 100-fold higher affinity for fungal enzymes than human CYP450. Features exceptional water solubility, high oral bioavailability (>90%), and long half-life (around 30 hours). Indicated for vaginal candidiasis, mucosal candidiasis (oropharyngeal, esophageal), cryptococcal meningitis, tinea pedis/corporis/cruris, and candidal prophylaxis in immunocompromised patients.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally with a glass of water, with or without food. For vaginal candidiasis, usually taken as a single 150 mg oral stat dose. For dermatophyte or systemic infections, take once weekly or daily as directed by your physician.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Nausea, abdominal discomfort, headache, diarrhea, mild rash, elevated liver enzymes. Rare/Severe: Severe hepatic toxicity/jaundice, QT interval prolongation and torsades de pointes, Stevens-Johnson syndrome, and anaphylaxis.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in patients with known hypersensitivity to azoles and concurrent administration with terfenadine or cisapride. Use with caution in patients with renal impairment (dose reduction required) or cardiac arrhythmias. Avoid in pregnancy (teratogenic risk with high/prolonged doses).
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered dermatologist or qualified medical practitioner before initiating, altering, or substituting any topical or systemic dermatological treatment.
Clotrimazole Cream 1%
Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.
Ketoconazole Lotion 2%
Ketoconazole topical cream (2% w/v) is a broad-spectrum imidazole antifungal agent. It disrupts fungal cell membranes by inhibiting 14-alpha-demethylase, eradicating dermatophytes, Candida species, and Malassezia yeasts. Indicated for tinea corporis, tinea cruris, tinea pedis, cutaneous candidiasis, and pityriasis versicolor.
Itraconazole Capsules 100 mg
Itraconazole is a synthetic triazole broad-spectrum antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase (CYP51), blocking conversion of lanosterol to ergosterol and destabilizing the fungal cell membrane. Features high lipophilicity and keratin affinity, persisting in nails for months after completion. Indicated for onychomycosis, dermatophytosis refractory to topical therapy, pityriasis versicolor, systemic aspergillosis, histoplasmosis, blastomycosis, and candidiasis.
Terbinafine Tablets 250mg
Terbinafine Hydrochloride is an oral synthetic allylamine broad-spectrum fungicidal agent on the WHO Model List of Essential Medicines. It non-competitively inhibits squalene epoxidase, an essential early enzyme in fungal ergosterol biosynthesis. This induces intracellular accumulation of toxic squalene and depletion of ergosterol, causing fungal cell membrane lysis. Highly lipophilic and keratophilic, accumulating in stratum corneum, hair follicles, and nails. Indicated for tinea unguium (onychomycosis of toenails/fingernails), extensive tinea corporis/cruris, and severe tinea pedis.